These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36006972)
21. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Blango MG; Mulvey MA Antimicrob Agents Chemother; 2010 May; 54(5):1855-63. PubMed ID: 20231390 [TBL] [Abstract][Full Text] [Related]
22. Association between virulence profile, biofilm formation and phylogenetic groups of Escherichia coli causing urinary tract infection and the commensal gut microbiota: A comparative analysis. Hashemizadeh Z; Kalantar-Neyestanaki D; Mansouri S Microb Pathog; 2017 Sep; 110():540-545. PubMed ID: 28760455 [TBL] [Abstract][Full Text] [Related]
23. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis. Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089 [TBL] [Abstract][Full Text] [Related]
24. Biofilm and Gene Expression Characteristics of the Carbapenem-Resistant Enterobacterales, Al-Bayati M; Samarasinghe S Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457654 [TBL] [Abstract][Full Text] [Related]
25. Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment. Eberly AR; Floyd KA; Beebout CJ; Colling SJ; Fitzgerald MJ; Stratton CW; Schmitz JE; Hadjifrangiskou M Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28973965 [TBL] [Abstract][Full Text] [Related]
27. Investigation of the Role of Virulence Gene in Biofilm Formation of Kadhim Mohammed R Arch Razi Inst; 2022 Apr; 77(2):915-921. PubMed ID: 36284946 [TBL] [Abstract][Full Text] [Related]
28. In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern. Ponnusamy P; Natarajan V; Sevanan M Asian Pac J Trop Med; 2012 Mar; 5(3):210-3. PubMed ID: 22305786 [TBL] [Abstract][Full Text] [Related]
29. Population Structure and Antimicrobial Resistance of Canine Uropathogenic Escherichia coli. LeCuyer TE; Byrne BA; Daniels JB; Diaz-Campos DV; Hammac GK; Miller CB; Besser TE; Davis MA J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29997200 [No Abstract] [Full Text] [Related]
31. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Soto SM; Smithson A; Horcajada JP; Martinez JA; Mensa JP; Vila J Clin Microbiol Infect; 2006 Oct; 12(10):1034-6. PubMed ID: 16961644 [TBL] [Abstract][Full Text] [Related]
32. Escherichia coli biofilm formation and recurrences of urinary tract infections in children. Tapiainen T; Hanni AM; Salo J; Ikäheimo I; Uhari M Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):111-5. PubMed ID: 23996047 [TBL] [Abstract][Full Text] [Related]
33. Outcome of acute urinary tract infections caused by uropathogenic Pullanhi U; Khan S; Vinod V; Mohan K; Kumar A Ann Afr Med; 2019; 18(3):138-142. PubMed ID: 31417014 [TBL] [Abstract][Full Text] [Related]
34. Experimental and clinical studies on fluoroquinolone-insusceptible Escherichia coli isolated from patients with urinary tract infections from 1994 to 2007. Wada K; Kariyama R; Mitsuhata R; Uehara S; Watanabe T; Monden K; Kumon H Acta Med Okayama; 2009 Oct; 63(5):263-72. PubMed ID: 19893602 [TBL] [Abstract][Full Text] [Related]
35. A Relationship Between O-Serotype, Antibiotic Susceptibility and Biofilm Formation in Uropathogenic Noie Oskouie A; Hasani A; Ahangarzadeh Rezaee M; Soroush Bar Haghi MH; Hasani A; Soltani E Microb Drug Resist; 2019; 25(6):951-958. PubMed ID: 30817229 [TBL] [Abstract][Full Text] [Related]
36. Molecular Epidemiology of Extraintestinal Pathogenic Yu Y; Hu B; Fan H; Zhang H; Lian S; Li H; Li S; Yan X; Wang S; Bai X Front Cell Infect Microbiol; 2021; 11():781068. PubMed ID: 34778114 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and Characterization of Carbon Dots Coated CaCO Kanwal A; Uzair B; Sajjad S; Samin G; Ali Khan B; Khan Leghari SA; Khan Niazi MB; Abbas S Microb Drug Resist; 2022 Jan; 28(1):106-119. PubMed ID: 34402682 [TBL] [Abstract][Full Text] [Related]
38. Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection. González MJ; Da Cunda P; Notejane M; Zunino P; Scavone P; Robino L Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31062019 [TBL] [Abstract][Full Text] [Related]
39. Infective endocarditis caused by Enterobacteriaceae: phenotypic and molecular characterization of Escherichia coli and Klebsiella pneumoniae in Rio de Janeiro, Brazil. Andrade NL; da Cruz Campos AC; Cabral AM; Damasco PH; Lo-Ten-Foe J; Rosa ACP; Damasco PV Braz J Microbiol; 2021 Dec; 52(4):1887-1896. PubMed ID: 34549374 [TBL] [Abstract][Full Text] [Related]
40. Revisiting the Escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection: contribution to intracellular biofilm development. Goller CC; Seed PC Virulence; 2010; 1(4):333-7. PubMed ID: 21178466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]